In Brief This Week: Agilent Technologies; Dionex; UCSF | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies this week said that it had completed the acquisition of certain assets of A2 Technologies for an undisclosed sum. Agilent inked the agreement last month to acquire specific assets of A2 Technologies, a Danbury, Conn.-based developer of Fourier transform infrared technology for lab and field use.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.